Trial
NCT01435993
Multiple Doses of Anti-NOGO A in Relapsing Forms of Multiple Sclerosis
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
GlaxoSmithKline
Collaborators
—
Condition
Multiple Sclerosis, Relapsing-Remitting
Intervention
GSK1223249
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-11-24